[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638525":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":10,"locations":21,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":72,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"University of Nottingham","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with T1DM aged 4 or older routinely using CGM systems undergoing elective surgery",null,"Patients (aged 4 or above) with a diagnosis of type 1 diabetes mellitus who routinely use a prescribed Abbott Libre-2, Abbott Libre-3, Dexcom G6 or Dexcom G7 glucose monitoring system to monitor glucose concentrations. Patients will scheduled to have a planned admission for elective surgery.",[13,17],{"name":14,"affiliation":15,"role":16},"James M Law, PhD, BMBS","University Hospitals of Derby and Burton NHS Foundation Trust, University of Nottingham","STUDY_DIRECTOR",{"name":18,"affiliation":19,"role":20},"James Armstrong, BMBS","Nottingham University Hospitals NHS Trust","PRINCIPAL_INVESTIGATOR",[22],{"facility":23,"status":10,"city":24,"state":10,"zip":10,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Queen's Medical Centre","Nottingham","United Kingdom","UK",{"type":28,"coordinates":29},"Point",[30,31],-1.15047,52.9536,{"lat":31,"lon":30},[34,38,40],{"name":18,"role":35,"phone":36,"phoneExt":10,"email":37},"CONTACT","0115 924 9924","james.armstrong8@nhs.net",{"name":14,"role":35,"phone":10,"phoneExt":10,"email":39},"james.law@nottingham.ac.uk",{"name":18,"role":20,"phone":10,"phoneExt":10,"email":10},{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100638525","diathermy-on-diabetes-glucose-monitoring-effectiveness-100638525",false,"NCT07583238","Diathermy On Diabetes Glucose Monitoring Effectiveness","Assessing the Impact of Intraoperative Diathermy on Accuracy and Functioning of Glucose Monitoring Systems","DODGE","Inclusion Criteria:\n\n* Diagnosis of type 1 diabetes mellitus.\n* Planned admission for elective surgery at Nottingham University Hospitals NHS Trust.\n* Currently routinely using a prescribed Abbott Libre-2, Abbott Libre-3, Dexcom G6 or Dexcom G7 glucose monitoring system to monitor glucose concentrations.\n* Aged 4 years or older on the day of surgery.\n* Ability to give informed consent \u002F ability of parent\u002Fcarer to give informed consent (as appropriate).\n\nExclusion Criteria:\n\n* Use of paracetamol above maximum dose within 7 days before the scheduled date of surgery (in adults with body weight under 51kg - maximum of 60mg\u002Fkg per day, in adults with body weight 51kg and above - maximum of 4g per day, in children - maximum dose as per their age as stated in the British National Formulary for Children)\n* Any use of hydroxyurea within 7 days before the scheduled date of surgery\n* Use of more than 500mg per day of ascorbic acid \u002F vitamin C within 7 days before the scheduled date of surgery\n* Currently taking medications as part of a clinical trial.","ALL","4 Years",{"count":54,"type":55},126,"ESTIMATED","1 Day","OBSERVATIONAL","The goal of this observational study is to investigate if diathermy (a surgical tool that uses electrical energy to control bleeding) has any affect on the accuracy and functioning of continuous glucose monitoring systems in adults and young people with Type 1 Diabetes. The main questions this study aims to answer is -\n\n\\- Does the accuracy of continuous glucose monitoring systems change after use of diathermy?\n\nParticipants will:\n\n* Have their height and weight checked.\n* Provide information about their medical history including type of diabetes, other medical conditions and any current medications they take.\n* Have paired glucose meter and sensor glucose measurements taken every 15-75 minutes from up to 4 hours before surgery until up to 4 hours after the end of surgery.\n* Have two blood samples taken to measure glucose levels, The first one will be before the use of diathermy and the second will be after the use of diathermy.",[60],"Type 1 Diabetes Mellitis",[62,63,64,65,66,67,68,69,70,71],"Continuous Glucose Monitoring Systems","Diathermy","Type 1 Diabetes Mellitus","Capillary blood glucose","Sensor blood glucose","Peri-operative care","Intra-operative T1DM management","pre-operative","post-operative","intraoperative","NOT_YET_RECRUITING","2026-05-06",{"date":75,"type":76},"2026-05-13","ACTUAL",{"date":78,"type":55},"2026-05",{"date":80,"type":55},"2027-02",{"name":5,"class":6},1]